2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Colorectal Neoplasms
12
Pain
11
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
7
Agnosia
6
Colonic Neoplasms
5
Cancer Pain
5
Neuralgia
4
Keratosis, Actinic
4
Head and Neck Neoplasms
4
Liver Neoplasms
3
Leiomyoma
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Mucositis
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Surveys and Questionnaires
6
Cisplatin
6
Brachytherapy
5
Doxorubicin
4
Docetaxel
4
Pemetrexed
3
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
FANG vaccine
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Lidocaine
×
Clear all
NCT01492179
2014-05-28
PoPuLAR
Örebro University, Sweden
Phase 4
Completed
60 enrolled